In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis

Chemotherapy

Volumn 50, Issue 6, 2004, Pages 308-313

  Carrillo Munoz A J ^a,e   Guglietta, A ^a   Palacin C ^a   Casals, J ^d   Del Valle, O ^a   Guardia C ^b   Rodriguez V ^a   Quindos G ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Ctr Atencio Primaria Dr Robert   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Rosco Diagnostica   (Denmark)

^e NONE   (Spain)

Author keywords

Antifungals; Clotrimazole; Dermatophytes; Econazole; Fluconazole; Isoconazole; Itraconazole; Ketoconazole; Miconazole; Scopulariopsis; Sertaconazole; Terbinafine; Tioconazole

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; ISOCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; SERTACONAZOLE; TERBINAFINE; TIOCONAZOLE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; DERMATOPHYTE; DRUG EFFICACY; FUNGAL DEVELOPMENT; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SCOPULARIOPSIS BREVICAULIS; TEMPERATURE; TIME;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; ASCOMYCOTA; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; IMIDAZOLES; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; NAPHTHALENES; THIOPHENES;

EID: 11244283313     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082631     Document Type: Article

References (37)

1. Ellis D, Marriott D, Hajjeh RA, Warnock D, Meyer W, Barton R: Epidemiology: Surveillance of fungal infections. Med Mycol 2000;38(suppl 1):173-182.
2. Seebacher C: Epidemiology, clinic and treatment of dermatomycoses caused by zoophilic dermatophytes. Mycoses 2000;43(suppl 1):4-7.
3. Berger AR: Common superficial fungal infections in patients with AIDS. Clin Infect Dis 1996;22:128-132.
4. Ray MC, Gately LE: Dermatology manifestations of HIV infection in AIDS. Infect Dis Clin North Am 1994;94:583-605.
5. del Palacio A, Garau M, González-Escalada A, Calvo MT: Trends in the treatment of dermatophytoses; in Kushwaha RKS, Guarro J (eds): Biology of Dermatophytes and Other Keratinophilic Fungi. Revista Iberoamericana de Micologia 2000, pp 148-158.
6. Carrillo-Muñoz AJ, Pemán J, Gobernado M: Nuevos antifúngicos. Rev Esp Quimioter 1999;12:181-204.
7. Carrillo-Muñoz AJ, Abarca L, Quindós G, Arévalo MP, Bornay-Llinares F, Cabañes FJ, Casals JB, Estivill D, González-Lama Z, Iglesias I, Hernández-Molina JM, Linares MJ, Martín-Mazuelos E, Payá MJ, San Millán R, Rubio MC: Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing. Rev Iberom Micol 1999;16:97-101.
8. Carrillo-Muñoz AJ, Brió S, Alonso R, del Valle O, Santos P, Quindós G: Ciclopiroxolamine: In vitro antifungal activity against clinical yeast isolates. Int J Antimicrob Agents 2002;20:375-379.
9. Carrillo-Muñoz AJ, Tur C, Montsant L, Carceller A, Hernández-Molina JM, Torres-Rodríguez JM: Resistencia in vitro al fluconazol e itraconazol en aislamientos clínicos de Candida spp y Cryptococcus neoformans. Rev Iberoam Micol 1997;14:50-54.
10. Carrillo-Muñoz AJ, Tur-Tur C, Hernández-Molina JM: Comparación de dos métodos para el estudio de la sensibilidad in vitro a sertaconazol en aislamientos clínicos de levaduras. Rev Esp Quimioter 1999;12:58-63.
11. Quindós G, Abarca L, Carrillo-Muñoz AJ, Arévalo MP, Bornay-Llinares FJ, Casals JB, Hernández-Molina JM, Iglesias I, Linares MJ, Martín-Mazuelos E, Pereiro Ferreirós M, Rezusta A, Rubio MC, Salesa R, San Millán R, Torres-Rodríguez JM: Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients. Rev Iberoam Micol 1999;16:102-105.
12. Cabañes FJ, Abarca L, Bragulat M, Bruguera T: Sensitivity of some strains of the genus Epidermophyton to different antifungal agents. Mycopathologia 1989;105:153-156.
13. Niewerth M, Splanemann V, Korting HC, Ring J, Abeck D: Antimicrobial susceptibility testing of dermatophytes - Comparison of the agar macrodilution and broth microdilution tests. Chemotherapy 1998;44:31-35.
14. Carrillo-Muñoz AJ, Fernández-Torres B, Cárdenes DC, Guarro J: In vitro activity of sertaconazole against dermatophyte mould isolates with reduced fluconazole susceptibility. Chemotherapy 2003;49:248-251.
15. Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro M Jr, Guarro J: In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000;46:390-394.
16. Fernández-Torres B, Cabañes FJ, Abarca L, Carrillo-Muñoz AJ, Inza I, Guarro J: Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002;40:3999-4003.
17. Fernández-Torres B, Carrillo-Muñoz AJ, Ortoneda M, Pujol I, Pastor J, Guarro J: Interlaboratory evaluation of the E-test® for antifungal susceptibility testing. Med Mycol 2003;41:125-130.
18. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA: Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000;38:341-344.
19. Ortíz JM: Sertaconazole (FI-7045): A new antifungal agent. Introduction. Arzneimittelforschung 1992;42:689-690.
20. User's guide: NeoSensitabs, ed 16. Taastrup, Rosco, 2003.
21. Gehrt A, Peter J, Pizzo PA, Walsh TJ: Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 1995;33:1302-1307.
22. Manavathu EK, Cutright J, Chandrasekar PH: Comparative study of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol 1999;37:858-861.
23. Brega EF, Gonzalez G, Fothergill AW, Sutton DA, Rinaldi MG: An in vitro evaluation of the new triazole antifungal agents against clinical isolates of dermatophytes in comparison with terbinafine, itraconazole, and fluconazole (abstract J205). Abstract of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, American Society for Microbiology, 2000, p 354.
24. Butty P, Lebecq JC, Mallié M, Bastide JM: Evaluation of the susceptibility of dermatophytes to antifungal drugs: A new technique. J Med Vet Mycol 1995;33:403-409.
25. Mock M, Monod M, Baudruz-Rosselet F, Panizzon RG: Tinea capitis dermatophytes: Susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 1998;197:361-367.
26. Norris HA, Elewski BE, Ghannoum MA: Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 1999;40:S9-S13.
27. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A. Wayne, National Committee for Clinical Laboratory Standards, 2002.
28. Martin-Mazuelos E, Aller AI, Morilla D, Montero O: Antifungal activity of sertaconazole in vitro against clinical isolates of Candida spp. Chemotherapy 1996;42:112-117.
29. Carrillo-Muñoz AJ, Tur-Tur C: Comparative study of antifungal activity of sertaconazole, terbinafine and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes. Chemotherapy 1997;43:387-392.
30. Carrillo-Muñoz AJ, Tur C, Torres J: In vitro activity of sertaconazole, bifonazole, ketoconazole and miconazole against yeasts of the Candida genus. J Antimicrob Chemother 1996;37:815-819.
31. Drohuet E, Dupont B: In vitro antifungal activity of sertaconazole. Arzneimittelforschung 1992;42:705-710.
32. Palacín C, Sacristán A, Ortiz JA: In vitro activity of sertaconazole. Arzneimittelforschung 1992;42:699-705.
33. Palacín C, Tarragó A, Sacristán A, Ortiz JA: Antifungal activity of sertaconazole in the cutaneous retention time test. J Mycol Med 1995;5:35-39.
34. Palacín C, Tarragó C, Agut J, Guglietta A: In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol 2001;23:61-64.
35. Carrillo-Muñoz AJ, Brió S, Quindós G, Palacín C, Guglietta A, Espinel-Ingroff A: Sertaconazole: In vitro antifungal activity against vaginal and other superficial yeast isolates. J Chemother 2001;13:555-562.
36. Wildfeuer A: The in vitro activity of fluconazole against fungi involved in dermal infections. Mycoses 1994;37:447-449.
37. Hazen KC: Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison. J Am Acad Dermatol 1998;38:S37-S41.